Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses
Authors:
- Elena Del TordelloETElena Del Tordello
- Alba FasoloAFAlba Fasolo
- Nigel J. TempertonNigel J. Temperton
- Grazia GalliGGGrazia Galli
- Chiara GentileCGChiara Gentile
- Emanuele MontomoliEMEmanuele Montomoli
- Anne K. HilbertAHAnne K. Hilbert
- Angelika BanzhoffABAngelika Banzhoff
- Giuseppe Del GiudiceGGGiuseppe Del Giudice
- John J. DonnellyJDJohn J. Donnelly
- Rino RappuoliRRRino Rappuoli
- 1 October 2009
- Vol. 27 (43) , 5998-6003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly AdultsPLOS ONE, 2009
- Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1New England Journal of Medicine, 2008
- Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case seriesThe Lancet, 2008
- Three Indonesian Clusters of H5N1 Virus Infection in 2005New England Journal of Medicine, 2006
- H5N1 vaccines: how prepared are we for a pandemic?The Lancet, 2006
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- Risk Factors for Human Infection with Avian Influenza A H5N1, Vietnam, 2004Emerging Infectious Diseases, 2006
- Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming StrategyThe Journal of Infectious Diseases, 2005
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- DETERMINANTS OF IMMUNITY TO INFLUENZA INFECTION IN MANBritish Medical Bulletin, 1979